0000000000962114

AUTHOR

Yong Zhou

showing 2 related works from this author

The DArk Matter Particle Explorer mission

2017

The DArk Matter Particle Explorer (DAMPE), one of the four scientific space science missions within the framework of the Strategic Pioneer Program on Space Science of the Chinese Academy of Sciences, is a general purpose high energy cosmic-ray and gamma-ray observatory, which was successfully launched on December 17th, 2015 from the Jiuquan Satellite Launch Center. The DAMPE scientific objectives include the study of galactic cosmic rays up to $\sim 10$ TeV and hundreds of TeV for electrons/gammas and nuclei respectively, and the search for dark matter signatures in their spectra. In this paper we illustrate the layout of the DAMPE instrument, and discuss the results of beam tests and calib…

Physics - Instrumentation and DetectorsSatellite launchesGamma ray observatoriesAstrophysicsGalactic cosmic rays01 natural sciencesCosmologyHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)ObservatoryDetectors and Experimental TechniquesCosmic rays dark matter space experiments010303 astronomy & astrophysicsphysics.ins-detSpace science missionsPhysicsHigh Energy Astrophysical Phenomena (astro-ph.HE)astro-ph.HEAstrophysics::Instrumentation and Methods for AstrophysicsInstrumentation and Detectors (physics.ins-det)CosmologyCosmology Galaxies Gamma rays Tellurium compounds Chinese Academy of Sciences Dark matter particles Explorer missions Galactic cosmic rays Gamma ray observatories Satellite launches Scientific objectives Space science missions Cosmic raysSpace ScienceAstrophysics - Instrumentation and Methods for AstrophysicsAstrophysics - High Energy Astrophysical PhenomenaParticle Physics - ExperimentAstrophysics and AstronomyAstrophysics::High Energy Astrophysical PhenomenaDark matterFOS: Physical sciencesCosmic raydark matterTellurium compounds0103 physical sciencesCosmic raysInstrumentation and Methods for Astrophysics (astro-ph.IM)010308 nuclear & particles physicshep-exGamma raysAstronomyAstronomy and AstrophysicsGalaxiesChinese academy of sciencesGalaxyScientific objectivesDark matter particlesChinese Academy of SciencesSatellitespace experimentsExplorer missionsastro-ph.IM
researchProduct

A subset of flavaglines inhibits KRAS nanoclustering and activation.

2020

The RAS oncogenes are frequently mutated in human cancers and among the three isoforms (KRAS, HRAS and NRAS), KRAS is the most frequently mutated oncogene. Here, we demonstrate that a subset of flavaglines, a class of natural anti-tumour drugs and chemical ligands of prohibitins, inhibit RAS GTP loading and oncogene activation in cells at nanomolar concentrations. Treatment with rocaglamide, the first discovered flavagline, inhibited the nanoclustering of KRAS, but not HRAS and NRAS, at specific phospholipid-enriched plasma membrane domains. We further demonstrate that plasma membrane-associated prohibitins directly interact with KRAS, phosphatidylserine and phosphatidic acid, and these int…

:Bioengineering [Engineering]Neuroblastoma RAS viral oncogene homologGene isoformLung NeoplasmsGTP'[SDV]Life Sciences [q-bio]AucunBiology: Biochemistry biophysics & molecular biology [F05] [Life sciences]medicine.disease_causeProto-Oncogene Proteins p21(ras)03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRocaglamideCarcinoma Non-Small-Cell LungmedicineKRASHumansdrug therapy;geneticsgeneticsHRASProhibitin: Biochimie biophysique & biologie moléculaire [F05] [Sciences du vivant]neoplasmsComputingMilieux_MISCELLANEOUS030304 developmental biology0303 health sciencesOncogeneLipid nanoclusterOncogenesCell Biologydigestive system diseases3. Good healthrespiratory tract diseasesPhospholipidchemistry030220 oncology & carcinogenesisMutationCancer researchKRASFlavaglineRocaglamideProhibitinSignal Transduction
researchProduct